and Key words This diploma thesis is focused on assessing the potential benefit of HLA epitopes for the prediction of de novo antibody production at kidney transplant recipients. The topic and patient selection criteria were selected in accordance with the 18th International HLA and Immunogenetics workshop (IHIWS), which is taking place in May 2022 in the Netherlands, where our data will also be contributed. Our aims were to compare HLA antigens mismatches (counted as total number of mismatched alleles) defined on the high-resolution level by NGS sequencing, HLA eplets mismatches defined by HLA matchmaker, and amino acid mismatches defined by HLA EMMA in their capacity to predict de novo antibody production and compare these results to othe...
International audienceHuman leukocyte antigen (HLA) mismatching and minimization of immunosuppressio...
Background. Human leukocyte antigen (HLA) matching strategies for kidney transplantation assign equa...
In kidney transplantation, eplet mismatches between donor and recipient have been associated with de...
Since the advent of kidney transplantation a key strategy for maximising graft survival by avoiding ...
Transplantation is the preferred treatment for end-stage renal disease, but premature graft loss is ...
Refinement of immunological pre-transplant risk assessment, specifically by improving the molecular ...
Renal transplantation is the first-choice treatment for end-stage renal disease. The importance of H...
Since the advent of kidney transplantation a key strategy for maximising graft survival by avoiding ...
The development of de novo donor-specific antibodies is related to the poor matching of the human le...
International audienceHuman leukocyte antigen (HLA) mismatching and minimization of immunosuppressio...
Background. Human leukocyte antigen (HLA) matching strategies for kidney transplantation assign equa...
In kidney transplantation, eplet mismatches between donor and recipient have been associated with de...
Since the advent of kidney transplantation a key strategy for maximising graft survival by avoiding ...
Transplantation is the preferred treatment for end-stage renal disease, but premature graft loss is ...
Refinement of immunological pre-transplant risk assessment, specifically by improving the molecular ...
Renal transplantation is the first-choice treatment for end-stage renal disease. The importance of H...
Since the advent of kidney transplantation a key strategy for maximising graft survival by avoiding ...
The development of de novo donor-specific antibodies is related to the poor matching of the human le...
International audienceHuman leukocyte antigen (HLA) mismatching and minimization of immunosuppressio...
Background. Human leukocyte antigen (HLA) matching strategies for kidney transplantation assign equa...
In kidney transplantation, eplet mismatches between donor and recipient have been associated with de...